Cordant, Inc. Checkpoint Therapeutics, Inc. Transaction History

Cordant, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 17, 2022	SELL	$0.97 - $1.77 $10,495 - $19,151	-10,820 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$2.5 - $3.53 $27,050 - $38,194	10,820 New	10,820 $36,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $299M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Cordant, Inc., based on Form 13F filings with the SEC.

Stay updated on Cordant, Inc. with notifications on news.